Positive HER2 status - Is it a discriminating factor for disease outcome in steroid receptor-positive early breast cancer patients treated with adjuvant endocrine therapy only?

被引：1
|
作者：
Susnjar, S. [1 ]
Vujasinovic, T. [2 ]
Abu Rabi, Z. [2 ]
Neskovic-Konstantinovic, Z. [1 ]
Milovanovic, Z. [3 ]
Jovanovic, D. [3 ]
Gavrilovic, D. [4 ]
Borojevic, N. [5 ]
机构：
[1] Inst Oncol & Radiol Serbia, Dept Med Oncol, Belgrade, Serbia
[2] Inst Oncol & Radiol Serbia, Expt Oncol Lab, Belgrade, Serbia
[3] Inst Oncol & Radiol Serbia, Dept Pathol, Belgrade, Serbia
[4] Inst Oncol & Radiol Serbia, Ctr Data, Belgrade, Serbia
[5] Inst Oncol & Radiol Serbia, Dept Radiotherapy, Belgrade, Serbia
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(10)70187-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：103 / 104
页数：2
相关论文
共 50 条
  • [1] EFFECT OF ADJUVANT ENDOCRINE THERAPY ON ESTROGEN RECEPTOR-NEGATIVE, PROGESTERONE RECEPTOR-POSITIVE AND HER2 NEGATIVE BREAST CANCER PATIENTS
    Shen, Jun
    Wang, Lin-bo
    Teng, Rong-yue
    Shen, Jian-guo
    ACTA MEDICA MEDITERRANEA, 2022, 38 (03): : 1595 - 1600
  • [2] Extended Adjuvant Endocrine Therapy in Hormone Receptor-Positive Early Breast Cancer
    Bracken-Clarke, Dara B.
    Lucas, Mairi W.
    Higgins, Michaela J.
    BREAST CARE, 2017, 12 (03) : 138 - 144
  • [3] INFLUENCE OF HER2 STATUS ON METASTATIC PATTERN IN POSTMENOPAUSAL HORMONE RECEPTOR POSITIVE BREAST CANCER PATIENTS TREATED WITH ADJUVANT TAMOXIFEN ONLY
    Spasojevic, Ivana Bozovic
    Susnjar, Snezana
    Kovacevic, Marijana Milovic
    Konstatinovic, Zora Neskovic
    Vujasinovic, Tijana
    Aburabi, Zaki
    Milovanovic, Zorka
    Gavrilovic, Dusica
    BREAST, 2013, 22 : S62 - S62
  • [4] Adjuvant therapy in breast cancer HER2 positive
    Olivito, V.
    De Simone, R.
    La Gattuta, G.
    Lucia, M.
    Dima, G.
    Talarico, R.
    Filippelli, G.
    ANNALS OF ONCOLOGY, 2006, 17 : VII146 - VII146
  • [5] The postmenopause: adjuvant endocrine therapy at an early stage of hormone receptor-positive breast cancer
    Brucker, S.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 (08) : 847 - 851
  • [6] Impact of adjuvant endocrine therapy on prognosis in small hormone receptor-positive, HER2-negative early breast cancer
    Yayoi Adachi
    Isao Oze
    Masataka Sawaki
    Masaya Hattori
    Akiyo Yoshimura
    Haruru Kotani
    Ayumi Kataoka
    Kayoko Sugino
    Nanae Horisawa
    Yuri Ozaki
    Yuka Endo
    Kazuki Nozawa
    Daiki Takatsuka
    Hiroji Iwata
    Breast Cancer, 2021, 28 : 1087 - 1095
  • [7] Impact of adjuvant endocrine therapy on prognosis in small hormone receptor-positive, HER2-negative early breast cancer
    Adachi, Yayoi
    Oze, Isao
    Sawaki, Masataka
    Hattori, Masaya
    Yoshimura, Akiyo
    Kotani, Haruru
    Kataoka, Ayumi
    Sugino, Kayoko
    Horisawa, Nanae
    Ozaki, Yuri
    Endo, Yuka
    Nozawa, Kazuki
    Takatsuka, Daiki
    Iwata, Hiroji
    BREAST CANCER, 2021, 28 (05) : 1087 - 1095
  • [8] The influence of steroid receptor (SR) content on disease outcome in early breast cancer patients treated with adjuvant endocrine therapy
    不详
    BREAST, 2005, 14 : S37 - S38
  • [9] Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen
    Yong Wha Moon
    Seho Park
    Joo Hyuk Sohn
    Dae Ryong Kang
    Ja Seung Koo
    Hyung Seok Park
    Hyun Cheol Chung
    Byeong-Woo Park
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 1123 - 1130
  • [10] Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen
    Moon, Yong Wha
    Park, Seho
    Sohn, Joo Hyuk
    Kang, Dae Ryong
    Koo, Ja Seung
    Park, Hyung Seok
    Chung, Hyun Cheol
    Park, Byeong-Woo
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (07) : 1123 - 1130
12345